Shield Therapeutics KOL Event on Iron Deficiency Treatment Innovation
About The Event
The webinar will feature presentations from Key Opinion Leaders (KOL’s):
- Dr. Lee P. Shulman, Northwestern University
- Dr. Carsten Schmidt, Fulda Hospital, Marburg University Medicine
Dr. Shulman will discuss the current treatment landscape and unmet medical need in treating patients with iron deficiency.
Dr. Schmidt will discuss Shield Therapeutic’s potential treatment solution Accrufer®/Feraccru®, a stable non-salt based oral therapy for adults with iron deficiency with or without anemia.
Greg Madison (Chief Executive Officer of Shield Therapeutics) will provide a company overview and update.
A live question and answer session will follow.